Report cover image

Antibiotics for Multidrug-Resistant Gram-positive Bacteria Market in China 2023

Publisher Gen Consulting Company
Published May 23, 2023
Length 37 Pages
SKU # GCC17999997

Description

Antibiotics for Multidrug-Resistant Gram-positive Bacteria Market in China 2023

Antibiotics for multidrug-resistant Gram-positive bacteria are a critical area of research and development as these types of bacteria have developed resistance to multiple types of antibiotics, making them difficult to treat. Some antibiotics that have been effective in treating certain types of multidrug-resistant Gram-positive bacteria include daptomycin, linezolid, teicoplanin, and tigecycline. The antibiotics for multidrug-resistant gram-positive bacteria market in China is anticipated to increase by USD 3.0 billion till 2029 at an average annual growth of 8.58 percent as per the latest market estimates.

This industry report offers market estimates of the China market, followed by a detailed analysis of the type, and route of administration. The China market data on antibiotics for multidrug-resistant gram-positive bacteria can be segmented by type: daptomycin, linezolid, teicoplanin, tigecycline. Antibiotics for multidrug-resistant gram-positive bacteria market is further segmented by route of administration: injectable, oral.

The competitive landscape of the industry has also been examined along with the profiles of the key players Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., North China Pharmaceutical Company Ltd., Pfizer Inc., Zhejiang Hisun Pharmaceutical Co. Ltd., Zhejiang Medicine Co. Ltd.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive coverage of the market across different market segments, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?
  • Get a detailed picture of the China Antibiotics for Multidrug-Resistant Gram-positive Bacteria Market
  • Identify segments/areas to invest in over the forecast period in the China Antibiotics for Multidrug-Resistant Gram-positive Bacteria Market
  • Understand the competitive environment, the market’s leading players
  • The market estimate for ease of analysis across scenarios in Excel format.
  • Strategy consulting and research support for three months.
  • Print authentication provided for the single-user license.

    • Table of Contents

    37 Pages
    Part 1. Summary
    Part 2. Introduction
    Study period
    Geographical scope
    Market segmentation
    Part 3. Antibiotics for multidrug-resistant gram-positive bacteria market overview
    Part 4. Market breakdown by type
    Daptomycin
    Linezolid
    Teicoplanin
    Tigecycline
    Part 5. Market breakdown by route of administration
    Injectable
    Oral
    Part 6. Key companies
    Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
    North China Pharmaceutical Company Ltd.
    Pfizer, Inc.
    Zhejiang Hisun Pharmaceutical Co., Ltd.
    Zhejiang Medicine Co., Ltd.
    Part 7. Methodology

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us